You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FOT12-CN-301

Showing 1 - 25 of 475
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Diffuse Scleroderma Trial in Shanghai (BRL-301)

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • +5 more
  • BRL-301
  • Shanghai, Shanghai, China
    Shanghai ChangZheng hospital
May 7, 2023

Renal Cell Carcinoma Trial (Cytoreductive Nephrectomy)

Not yet recruiting
  • Renal Cell Carcinoma
  • Cytoreductive Nephrectomy
  • (no location specified)
Jul 3, 2023

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Miami, Florida
  • +1 more
Oct 31, 2023

Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive

Recruiting
  • Kidney Cancer
  • +2 more
  • Cytoreductive nephrectomy±metastasectomy
  • Human-derived materials sampling
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 2, 2023

Opioid Use Disorder Trial in Tahlequah, Seattle (Treatment as usual (TAU), CHaRRM-CN)

Recruiting
  • Opioid Use Disorder
  • Treatment as usual (TAU)
  • CHaRRM-CN
  • Tahlequah, Oklahoma
  • +1 more
Feb 15, 2023

Systemic Lupus Erythematosus (SLE) Trial (BRL-301)

Not yet recruiting
  • Systemic Lupus Erythematosus (SLE)
  • BRL-301
  • (no location specified)
Aug 13, 2023

Charcot Joint of Foot Trial in Chandigarh (Danosumab)

Active, not recruiting
  • Charcot Joint of Foot
  • Chandigarh, India
    Deptt of Endocrinology
Mar 21, 2023

Cocaine Use Disorder, Substance Use Disorders, Healthy Volunteers Trial in Overland Park (TMP-301, Placebo)

Active, not recruiting
  • Cocaine Use Disorder
  • +2 more
  • Overland Park, Kansas
    Altasciences
Aug 29, 2023

Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)

Recruiting
  • Melanoma
  • Metastatic Melanoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 12, 2023

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Recruiting
  • Early Onset Alzheimer Disease
  • +2 more
  • Sun City, Arizona
  • +18 more
Mar 15, 2022

Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

Terminated
  • Advanced Solid Tumor
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +1 more
Dec 18, 2022

Stroke Trial in Sherbrooke (Strength training intervention, Cranial nerve non-invasive neuromodulation (CN-NINM))

Recruiting
  • Stroke
  • Strength training intervention
  • Cranial nerve non-invasive neuromodulation (CN-NINM)
  • Sherbrooke, Quebec, Canada
    Centre de recherche sur le vieillissement
Nov 2, 2022

China Longitudinal Aging and Cognitive Impairment Study

Recruiting
  • Aging
  • +3 more
  • None of intervention
  • Hangzhou, Zhejiang, China
  • +1 more
Jul 18, 2022

Pancreatic Cancer, Cancer of the Pancreas, Pancreas Cancer Trial in Saint Louis (CDX-301, CDX-1140, Research blood draw)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

Head Neck Cancer, Intratumoral Injection Trial in Chicago (RiMO-301)

Recruiting
  • Head Neck Cancer
  • Intratumoral Injection
  • Chicago, Illinois
    University of Illinois at Chicago
Apr 28, 2023

Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)

Recruiting
  • Transfusion Dependent Beta Thalassemia
  • +3 more
  • EDIT-301
  • Oakland, California
  • +3 more
Jan 3, 2023

Sickle Cell Disease, Hemoglobinopathies Trial in Canada, United States (EDIT-301)

Recruiting
  • Sickle Cell Disease
  • Hemoglobinopathies
  • EDIT-301
  • Oakland, California
  • +18 more
Jan 10, 2023

Parkinson Disease Trial (Gemfibrozil, Placebo)

Not yet recruiting
  • Parkinson Disease
  • (no location specified)
Jun 27, 2023

Perennial Allergic Rhinitis, Rhinitis, Allergic Trial in Mississauga (Treatment A, Treatment B, Treatment C)

Completed
  • Perennial Allergic Rhinitis
  • Rhinitis, Allergic
  • Treatment A
  • +2 more
  • Mississauga, Canada
    Cliantha Research
Apr 6, 2022

Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Worldwide (Camidanlumab Tesirine)

Active, not recruiting
  • Relapsed Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Camidanlumab Tesirine
  • Scottsdale, Arizona
  • +72 more
Dec 15, 2022

Retinitis Pigmentosa Trial (KIO-301)

Recruiting
  • Retinitis Pigmentosa
  • Adelaide, South Australia, Australia
    Royal Adeliade Hospital
Dec 22, 2022

Hospitalized Heart Failure With Different Serum Potassium Levels

Completed
  • Hyperkalemia
  • +2 more
    • Shanghai, Shanghai, China
      Research Site
    Aug 12, 2022

    Gastric Cancer Trial in Taiwan (AST-301, rhuGM-CSF)

    Not yet recruiting
    • Gastric Cancer
    • Kaohsiung, Taiwan
    • +5 more
    Mar 14, 2023

    COVID-19 Trial (LMN-301)

    Not yet recruiting
    • COVID-19
    • LMN-301
    • (no location specified)
    Sep 1, 2023

    Non-proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (KSI-301, Sham injection)

    Active, not recruiting
    • Non-proliferative Diabetic Retinopathy
    • Phoenix, Arizona
    • +46 more
    Sep 22, 2022